tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Mccarthy, 213 are a BUY (84.86%), 35 are a HOLD (13.94%), 3 are a SELL (1.2%).
Analyst Jason Mccarthy, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 46.07% that have a potential upside of 59.44% achieved within 308 days.
Jason Mccarthy’s has documented 486 price targets and ratings displayed on 83 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARTL, Artelo Biosciences at 19-Nov-2025.
Analyst best performing recommendations are on CRDF (CARDIFF ONCOLOGY).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/17/2024. The price target of $12 was fulfilled within 13 days with a profit of $6.92 (136.22%) receiving and performance score of 104.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$20
$14.85 (288.35%)
$20
2 months 13 days ago
(13-Oct-2025)
0/10 (0%)
$14.59 (269.69%)
Buy
$20
$14.85 (288.35%)
$19
4 months 11 days ago
(15-Aug-2025)
0/2 (0%)
$12.87 (180.50%)
Buy
$20
$14.85 (288.35%)
$21
7 months 10 days ago
(16-May-2025)
0/2 (0%)
$13.9 (227.87%)
Buy
$15
$9.85 (191.26%)
$15
9 months 2 days ago
(24-Mar-2025)
0/2 (0%)
$9.88 (192.97%)
Buy
$18
$12.85 (249.51%)
$18
1 years 1 months 27 days ago
(29-Oct-2024)
1/5 (20%)
$11.43 (173.97%)
61
Which stock is Jason Mccarthy is most bullish on?
Which stock is Jason Mccarthy is most reserved on?
What Year was the first public recommendation made by Jason Mccarthy?
